Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf semaglutide is making you throw up, you're not alone — vomiting is one of the most commonly reported side effects during the early weeks of treatment, and for most people it settles as the body adjusts. It's caused by semaglutide's action on the gut and brain, which slows digestion and changes appetite signals. That said, vomiting that is severe, persistent, or accompanied by sharp stomach pain needs prompt medical attention. Because semaglutide (sold as Wegovy for weight management) is a prescription-only medicine, a registered prescriber should always be your first port of call when a side effect is affecting your daily life — not a forum thread or a dosing adjustment made without guidance.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide activates GLP-1 receptors in both the gut and the brainstem's area postrema, which is sometimes called the body's vomiting centre. The result is a simultaneous slowing of how quickly food leaves the stomach and a direct signal to the brain that something needs to come up. This is not a flaw or an allergy, it is the pharmacology working as designed, but at a level your system hasn't yet adapted to.
The timing matters. Vomiting tends to peak in the first few days after each new dose or dose increase, then ease as the body recalibrates. If you've just moved from 0.5 mg to 1.0 mg, or from 1.7 mg up to 2.4 mg, expect the same adjustment curve to repeat. The NHS patient information for semaglutide confirms vomiting as a common side effect, meaning it affects more than one in ten people, so this reaction is well-documented, not rare or unusual.
One thing our prescribers hear regularly: people assume vomiting means the medicine is harming them, and they stop abruptly. Stopping without clinical advice isn't the right call either. If you're finding it genuinely unbearable, contact your prescribing service so a clinician can decide whether a temporary dose hold or other adjustment makes sense.
There is good evidence from patient experience and clinical guidance that eating habits have a significant effect on how much nausea and vomiting semaglutide causes. Smaller meals are the single most consistently reported fix, a stomach that is already slower to empty will struggle harder with a large volume of food.
Specific patterns worth trying: eating slowly, stopping at the first hint of fullness (not waiting for it to build), keeping high-fat and heavily spiced meals to a minimum, and avoiding lying down within a couple of hours of eating. Staying well hydrated matters too, because repeated vomiting carries a real dehydration risk. Plain fluids, taken in small, frequent sips rather than large glasses, are usually better tolerated.
Timing your injection can also help. Some people find that injecting on an evening when they can rest (rather than on a busy Monday morning before work) reduces the peak nausea window. There is no strong clinical evidence for one specific day being universally better, but if you notice a pattern around your injection day, mentioning it to your prescriber gives them something concrete to work with. For more detail on nausea and vomiting patterns that readers describe, the question of whether Wegovy can cause vomiting is covered in depth elsewhere on this site.
Most vomiting on semaglutide is unpleasant but not dangerous. Certain patterns are different. Seek medical help urgently if you experience any of the following: severe stomach pain, particularly pain that is persistent and spreads towards the back, which can be a sign of acute pancreatitis; vomiting so frequent that you cannot keep fluids down for more than a few hours; signs of dehydration such as very dark urine, dizziness when standing, or confusion; or any allergic reaction (swelling of the face, lips or throat, difficulty breathing).
In January 2026 the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines including semaglutide. The update recommended that patients and clinicians treat severe persistent abdominal pain as a reason to stop treatment and seek assessment immediately. This doesn't mean every bout of nausea is pancreatitis (it is genuinely rare) but the symptom pattern is important to know.
You can report suspected side effects directly through the MHRA's Yellow Card scheme. It takes minutes and contributes to ongoing safety monitoring for these medicines across the UK. If you are unsure whether what you're experiencing warrants urgent attention, err on the side of calling NHS 111 or your GP rather than waiting.
If vomiting is still frequent after two to three weeks at the same dose, and the practical steps above haven't helped much, that is a clinical conversation, not something to manage alone. A prescriber can assess whether a temporary dose reduction is appropriate, explore whether another factor is contributing (other medicines, an underlying GI condition), or consider whether this treatment is the right fit for you. If what you're dealing with feels more intense than expected, our page on Wegovy making you throw up covers the specific experiences readers share and what they found helped.
This is one reason the structure of any legitimate semaglutide service matters. Reviewing whether a patient is tolerating treatment isn't optional; it is part of responsible prescribing. Details of what responsible private prescribing involves (including what to look for in any provider) are laid out on our about us page. If you're thinking about what ongoing support should look like, you might also find it useful to read about what people report after stopping Wegovy, including those who stopped specifically because of side effects.
For those weighing up whether to continue, the cost of treatment is sometimes part of the picture. An honest overview of what private semaglutide costs in the UK (and what the price should include) is on our Wegovy cost page. If you want to explore whether treatment is suitable for you, checking your eligibility with our prescribers is the place to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.